» Articles » PMID: 15387447

Long-term Stability of Endogenous B-type Natriuretic Peptide (BNP) and Amino Terminal ProBNP (NT-proBNP) in Frozen Plasma Samples

Overview
Specialties Biochemistry
Pathology
Date 2004 Sep 25
PMID 15387447
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to assess the long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in plasma samples stored at -20 degrees C without addition of protease inhibitors (e.g., aprotinin). Stability of BNP and NT-proBNP was tested in 60 EDTA plasma samples with BNP values between 30 and 420 pg/ml. Initial BNP and NT-proBNP plasma concentrations were determined within four hours after blood collection using the AxSYM BNP and the Elecsys NT-proBNP assays. Subsequently, all samples were stored at -20 degrees C and were thawed for the second BNP and NT-proBNP determination on the two instruments after one day, 30 days, 60 days, 90 days and 120 days, respectively. Mean recovery (i.e., residual immunoreactivity) of BNP and NT-proBNP expressed in percent of the initial value for the given time interval of storage was calculated. Mean recovery of BNP was less than 70% after one day of storage at -20 degrees C and decreased to less than 50% after two to four months of storage (e.g., recovery of endogenous BNP after three months of storage at -20 degrees C ranging from 0% to 71%). In contrast, mean recovery of NT-proBNP was generally greater than 90%, irrespective of the duration of storage at -20 degrees C (e.g., recovery of endogenous NT-proBNP after three months of storage at -20 degrees C ranging from 91% to 112%). In conclusion, the determination of endogenous BNP with the AxSYM assay using frozen plasma samples may not be valid under the conditions tested. In contrast, NT-proBNP as measured by the Elecsys assay may be stored at -20 degrees C for at least four months without a relevant loss of the immunoreactive analyte.

Citing Articles

Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome.

Katsioupa M, Kourampi I, Oikonomou E, Tsigkou V, Theofilis P, Charalambous G Life (Basel). 2023; 13(10).

PMID: 37895374 PMC: 10608753. DOI: 10.3390/life13101992.


Effects of the Dietary Approaches to Stop Hypertension Diet on Change in Cardiac Biomarkers Over Time: Results From the DASH-Sodium Trial.

Belanger M, Kovell L, Turkson-Ocran R, Mukamal K, Liu X, Appel L J Am Heart Assoc. 2023; 12(2):e026684.

PMID: 36628985 PMC: 9939071. DOI: 10.1161/JAHA.122.026684.


Analysis of the B-Type Natriuretic Peptide and the Aminoterminal-Pro-B-Type Natriuretic Peptide in Different Parrot, Raptor and Owl Species.

Hennig A, Mohr L, Fehr M, Legler M Vet Sci. 2022; 9(2).

PMID: 35202316 PMC: 8880403. DOI: 10.3390/vetsci9020064.


Association of Annual N-Terminal Pro-Brain Natriuretic Peptide Measurements With Clinical Events in Patients With Asymptomatic Nonsevere Aortic Stenosis: A Post Hoc Substudy of the SEAS Trial.

Hadziselimovic E, Greve A, Sajadieh A, Olsen M, Kesaniemi Y, Nienaber C JAMA Cardiol. 2022; 7(4):435-444.

PMID: 35171199 PMC: 8851368. DOI: 10.1001/jamacardio.2021.5916.


N-Terminal Pro Brain Natriuretic Peptide, sST2, and Galectin-3 Levels in Breast Cancer Survivors.

Patel S, Herrmann J, Vierkant R, Olson J, Couch F, Hazim A J Clin Med. 2021; 10(15).

PMID: 34362097 PMC: 8346981. DOI: 10.3390/jcm10153313.